The Patent Finder

Ultivue, Inc.

15 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
May 2037
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 13, 2026
    The maintenance fee for Methods and compositions for sequentially detecting targets (US 11,674,178) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
  • 2 fees due Mar 12 to 19, 2027 · next Mar 12
  • 1 fee due Apr 3, 2027
    The maintenance fee for Multiplexed Imaging Using Strand Displacement (US 11,773,428) comes due Apr 3, 2027. Unpaid by Oct 4, 2027, it lapses early.
  • 2 fees due Sep 5 to 19, 2027 · next Sep 5

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 12,486,530Multiplexed Imaging Using Strand Displacement
In force
 · Medium confidence
In forceMedium confidence
US 11,773,428Multiplexed Imaging Using Strand Displacement
In force
 · Low confidence
In forceLow confidence
US 11,060,132Multiplexed Imaging Using Strand Displacement
In force
 · Medium confidence
In forceMedium confidence
US 11,079,388Super-resolution immunofluorescence with diffraction-limited preview
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,754,562Methods for Multiplex Imaging Using Labeled Nucleic Acid Imaging Agents
In force
 · Medium confidence
In forceMedium confidence
US 12,234,503Methods for Multiplex Imaging Using Labeled Nucleic Acid Imaging Agents
In force
 · High confidence
In forceHigh confidence
US 11,382,986Compositions and Methods to Expedite Antibody-Based Exchange Imaging
In force
 · High confidence
In forceHigh confidence
US 10,246,738DNA-Antigen Exchange and Amplification
In force
 · High confidence
In forceHigh confidence
US 11,920,186DNA-Antigen Exchange and Amplification
In force
 · High confidence
In forceHigh confidence
US 11,279,968DNA-Antigen Exchange and Amplification
In force
 · High confidence
In forceHigh confidence
10 of 15 patents shown.
Pro members see all 15.
Pro members: see all 15 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 pending · 3 abandoned · 4 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited